Vielot and her colleagues found that among 3.45 million people evaluated across 12 emulated trials in analysis 1, the one-year vaccine effectiveness of at least one Shingrix dose was 56.1% against any ...
New research reveals many Australians over 50 underestimate their shingles risk. Learn the signs, symptoms and how to protect ...
Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals· Marketing authorisation in EU expected in December ...
The idea that you can “catch” shingles is one of the more common misconceptions I hear from patients who arrive worried ...
Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) is the first and only vaccine approved in this population in ChinaApproval adds to existing indication in adults aged 50 and overApproximately six ...
China NMPA approves GSK’s Shingrix for prevention of shingles in adults aged 18 and over who are at increased risk due to immunodeficiency or immunosuppression: London, UK Wedne ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback